Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

Author:

Pozzi SabinaORCID,Scomparin Anna,Israeli Dangoor SaharORCID,Rodriguez Ajamil Daniel,Ofek PaulaORCID,Neufeld LenaORCID,Krivitsky Adva,Vaskovich-Koubi Daniella,Kleiner RonORCID,Dey PradipORCID,Koshrovski-Michael ShaniORCID,Reisman Noa,Satchi-Fainaro RonitORCID

Funder

Melanoma Research Alliance

ERC

European Commission

Israel Cancer Association

Israel Science Foundation

Israel Cancer Research Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference322 articles.

1. Observations of the living developing nerve fiber;Harrison;Anatom. Rec.,1907

2. Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System;Li;Sci. Rep.,2018

3. Bioprinting the Cancer Microenvironment;Zhang;ACS Biomater. Sci. Eng.,2016

4. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures;Kapałczyńska;Arch Med. Sci.,2018

5. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?;Hoarau-Véchot;Int. J. Mol. Sci.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3